A new weight-loss drug which contains anti-addiction drug naltrexone has become approved by the U.S. Food and Drug Administration today, the agency said in a statement.
Using two separate drugs to shed pounds can be very effective you can find combinations before the FDA now awaiting approval. When dealing with weight-loss and the individuals who go through it you need to err assisting caution and allow the FDA do its job and demand some investigation be done so your public understands the side effects and hazards of the medications before we bring them. Keep in mind that drug companies are in business to make money and that they would say everything to keep people on the medications.
Researchers found that participants using this drug for the year, dropped a few pounds within one month and have kept the body weight off through the entire 56 weeks with the study. Contrave is a combination from the drugs naltrexone and bupropion, which appears to reflect a new trend of weight-loss drugs which can be made up of several active ingredient, which might make them more effective and safer.
Combo-pilling will be the newest fad or better yet the newest in the future under scrutiny and so it is just more publicly known recently, comb-pilling for losing weight has been around since the eighties. The biggest reason that using a combination of pills is starting to become popular could be the fact that by right now there are not any long term prescription weightloss pills that have been approved by the FDA other than orlistat. The truly disturbing part is always that doctors are prescribing these combinations of medications and some of the combinations are actually rejected or have yet to be licensed by the FDA.
Seizures certainly are a side effect with Contrave and really should not be taken in those with seizure disorders. The drug could also raise blood pressure level and pulse rate, and really should not be used in those with a history of heart attack or stroke in the previous six months. Blood pressure and pulse should also be measured before beginning the drug and throughout therapy with the drug.
The FDA also warned that Contrave can raise hypertension and heartrate and must not be used in patients with uncontrolled high hypertension, as well as by you are not heart-related and cerebrovascular (circulatory dysfunction impacting the brain) disease. Patients which has a history of cardiac arrest or stroke in the previous six months, life-threatening arrhythmias, or congestive heart failure were excluded through the clinical trials. Those taking Contrave must have their heart-rate and pulse monitored regularly. In addition, because the compound includes bupropion, Contrave comes which has a boxed warning to alert physicians and patients for the increased risk of suicidal thoughts and behaviors connected with antidepressant drugs. The warning also notes that serious neuropsychiatric events happen to be reported in patients taking bupropion for smoking cessation.
Approving a drug using this type of many potentially lethal unwanted side effects is inconsistent using the mission statement of the FDA. The power of the drug manufacturing lobby is blatantly evident in the approval of several drugs requiring 'post-marketing' studies that are clearly significant to overall drug safety inside US.